Locations in India
Our API sites in India
We have 2 sites in India, in Vizag (Andhra Pradesh region) and in Chennai (Tamil Nadu region) dedicated to development and manufacturing services for small-molecule Generic APIs, Amino Acids and intermediates.
Our site in Vizag
- PharmaZell plant
- Process development, pilot and large-scale commercial production
- Generic APIs and CDMO services
- cGMP kilo laboratory
Located in Vizag (South India, Andhra Pradesh), this site was established in the year 2007. This state-of-the art facility with 62,700 sqm space is dedicated to development and manufacturing services for small-molecule Generic APIs . More than 250 employees produce a wide range of commercial APIs for specific therapeutic areas such as anti-inflammatory, anti-hypertensive & diuretic, and multiple sclerosis. The site also supports our global CDMO services.
Most recent inspections:
- Indian Health authority 2022
- FDA (US), regular, 2021
- WHO GMP 2021
- CDSCO (IN), regular, 2018
- PMDA (JP), 2018
- Government of Upper Bavaria, competent authority (Germany), regularly, 2017
- KFDA (Korea), 2011
Our site in Chennai
- PharmaZell plant
- Small molecule APIs, Amino Acids and intermediates
- Electrochemical reactions and hydrogenations
Located in Chennai (India, East coast), this site was founded in 1994 to scale up and manufacture on large scale small molecule APIs, Amino Acids and intermediates. It is highly experienced in technologies such as electrochemical reactions and hydrogenations. With a qualified team of more than 200 employees more than 1,500 tons of small molecule APIs are produced each year.
Most recent inspections:
- Anvisa (BRA) 2023
- WHO GMP 2023
- PMDA (JP), 2023
- CDSCO (IN), regular, 2019
- FDA (US), regular, 2017
- Government of Upper Bavaria, competent authority (Germany), regularly, 2017
- KFDA (Korea), 2011
- Audits for certification, surveillance, and recertification of QMS, EMS and HACCP
- Regular customer audits
